Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Celerion Inc.
EIR
•Celerion Inc.•June 5, 2019

Celerion Inc. – FDA EIR, Jun 5, 2019

Record Details

An FDA surveillance inspection of Celerion Inc. in Tempe, AZ, was conducted from May 28 to June 5, 2019. This routine inspection, falling under the Bioresearch Monitoring Compliance Program (CP 7348.003), focused on adherence to Good Clinical Practices (GCPs) for two specific study protocols, reviewing subjects’ records, test article management, and sample handling. The inspection's primary finding was that no FDA-483, Inspectional Observations, were issued to Celerion Inc. at its conclusion, indicating a general compliance with regulatory expectations during the review period. However, one notable observation was that blinding envelopes for Protocol # (b) (4) were not maintained at the facility, having been returned to the study sponsor. The firm indicated a new internal process would be implemented to store randomization schedules within the regulatory binder to address such documentation. During the inspection, an FDA investigator collected a sample of retention drug products (Sample # 1086473) for Protocol # (b) (4). The facility demonstrated no refusals of inspection procedures, and all discussions with management concluded without further issues. This report confirms the site's overall compliance and its proactive step to improve documentation practices regarding randomization schedules.

Company
Celerion Inc.
Inspection date
June 5, 2019
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Philip Bach (company_representative)
  • Terry O"Reilly (investigator)
  • Jeffrey Pearl (investigator)
  • Dzanin Nasic (company_representative)
  • Amer Nasic (recipient)
View Company Profile

ID · c59def84-6920-4a9f-86f0-7c4f8995f749

Violation Codes1
21 CFR 312

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Celerion Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.